NuGen Medical Devices Inc.
NuGen Medical Devices Inc. (NGMDF) Financial Performance & Income Statement Overview
Review NuGen Medical Devices Inc. (NGMDF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
NuGen Medical Devices Inc. (NGMDF) Income Statement & Financial Overview
Explore comprehensive income reports for NuGen Medical Devices Inc. NGMDF, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $415746.00 | $531815.00 | $14924.00 | $47394.00 |
| Cost of Revenue | $190770.00 | $270319.00 | $5797.00 | $193333.00 |
| Gross Profit | $224976.00 | $261496.00 | $9127.00 | -$145939.00 |
| Gross Profit Ratio | $0.54 | $0.49 | $0.61 | -$3.08 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $131321.00 |
| SG&A Expenses | $934750.00 | $2.24M | $522189.00 | $1.34M |
| Operating Expenses | $1.09M | $2.39M | $682080.00 | $1.34M |
| Total Costs & Expenses | $1.28M | $2.66M | $687877.00 | $1.53M |
| Interest Income | $0.00 | -$33393.00 | $0.00 | $0.00 |
| Interest Expense | $715725.00 | $330843.00 | $765564.00 | $306866.00 |
| Depreciation & Amortization | $158139.00 | $155423.00 | $159891.00 | $172277.00 |
| EBITDA | $1.38M | -$2.46M | -$25412.00 | -$1.31M |
| EBITDA Ratio | $3.32 | -$4.63 | -$1.70 | -$27.68 |
| Operating Income | -$867913.00 | -$2.13M | -$672953.00 | -$1.48M |
| Operating Income Ratio | -$2.09 | -$4.010 | -$45.09 | -$31.31 |
| Other Income/Expenses (Net) | $1.37M | -$815552.00 | -$277914.00 | -$341287.00 |
| Income Before Tax | $506260.00 | -$2.95M | -$950867.00 | -$1.83M |
| Income Before Tax Ratio | $1.22 | -$5.54 | -$63.71 | -$38.54 |
| Income Tax Expense | -$3973.00 | $10712.00 | $0.00 | $3.00 |
| Net Income | $510233.00 | -$2.96M | -$950867.00 | -$1.83M |
| Net Income Ratio | $1.23 | -$5.56 | -$63.71 | -$38.54 |
| EPS | $0.00 | -$0.01 | -$0.004 | -$0.009 |
| Diluted EPS | $0.00 | -$0.01 | -$0.004 | -$0.009 |
| Weighted Avg Shares Outstanding | $217.32M | $217.32M | $215.88M | $204.98M |
| Weighted Avg Shares Outstanding (Diluted) | $217.32M | $217.32M | $215.88M | $204.98M |
Over the past four quarters, NuGen Medical Devices Inc. demonstrated steady revenue growth, increasing from $47394.00 in Q1 2024 to $415746.00 in Q4 2024. Operating income reached -$867913.00 in Q4 2024, maintaining a consistent -209% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $1.38M, reflecting operational efficiency. Net income rose to $510233.00, with EPS at $0.00. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan